India · Delayed Price · Currency is INR Unihealth Hospitals Statistics
Total Valuation
NSE:UNIHEALTH has a market cap or net worth of INR 8.72 billion. The enterprise value is 9.54 billion.
| Market Cap | 8.72B |
| Enterprise Value | 9.54B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:UNIHEALTH has 15.40 million shares outstanding. The number of shares has increased by 1.53% in one year.
| Current Share Class | 15.40M |
| Shares Outstanding | 15.40M |
| Shares Change (YoY) | +1.53% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 64.94% |
| Owned by Institutions (%) | n/a |
| Float | 5.40M |
Valuation Ratios
The trailing PE ratio is 34.26.
| PE Ratio | 34.26 |
| Forward PE | n/a |
| PS Ratio | 6.60 |
| PB Ratio | 4.40 |
| P/TBV Ratio | 6.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 153.12 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 36.94 |
| EV / Sales | 7.23 |
| EV / EBITDA | 17.65 |
| EV / EBIT | 21.74 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.33, with a Debt / Equity ratio of 0.17.
| Current Ratio | 5.33 |
| Quick Ratio | 4.58 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.61 |
| Debt / FCF | -1.28 |
| Interest Coverage | 18.64 |
Financial Efficiency
Return on equity (ROE) is 30.05% and return on invested capital (ROIC) is 21.68%.
| Return on Equity (ROE) | 30.05% |
| Return on Assets (ROA) | 14.11% |
| Return on Invested Capital (ROIC) | 21.68% |
| Return on Capital Employed (ROCE) | 19.39% |
| Weighted Average Cost of Capital (WACC) | 1.67% |
| Revenue Per Employee | 2.64M |
| Profits Per Employee | 516,606 |
| Employee Count | 500 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 9.69 |
Taxes
In the past 12 months, NSE:UNIHEALTH has paid 8.46 million in taxes.
| Income Tax | 8.46M |
| Effective Tax Rate | 1.82% |
Stock Price Statistics
The stock price has increased by +216.29% in the last 52 weeks. The beta is -0.51, so NSE:UNIHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | -0.51 |
| 52-Week Price Change | +216.29% |
| 50-Day Moving Average | 465.33 |
| 200-Day Moving Average | 311.76 |
| Relative Strength Index (RSI) | 73.33 |
| Average Volume (20 Days) | 47,325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:UNIHEALTH had revenue of INR 1.32 billion and earned 258.30 million in profits. Earnings per share was 16.52.
| Revenue | 1.32B |
| Gross Profit | 878.42M |
| Operating Income | 436.10M |
| Pretax Income | 465.72M |
| Net Income | 258.30M |
| EBITDA | 537.94M |
| EBIT | 436.10M |
| Earnings Per Share (EPS) | 16.52 |
Balance Sheet
The company has 104.46 million in cash and 327.44 million in debt, with a net cash position of -222.98 million or -14.48 per share.
| Cash & Cash Equivalents | 104.46M |
| Total Debt | 327.44M |
| Net Cash | -222.98M |
| Net Cash Per Share | -14.48 |
| Equity (Book Value) | 1.98B |
| Book Value Per Share | 88.36 |
| Working Capital | 1.27B |
Cash Flow
In the last 12 months, operating cash flow was 56.93 million and capital expenditures -312.25 million, giving a free cash flow of -255.32 million.
| Operating Cash Flow | 56.93M |
| Capital Expenditures | -312.25M |
| Depreciation & Amortization | 101.84M |
| Net Borrowing | 105.46M |
| Free Cash Flow | -255.32M |
| FCF Per Share | -16.58 |
Margins
Gross margin is 66.55%, with operating and profit margins of 33.04% and 19.57%.
| Gross Margin | 66.55% |
| Operating Margin | 33.04% |
| Pretax Margin | 35.28% |
| Profit Margin | 19.57% |
| EBITDA Margin | 40.76% |
| EBIT Margin | 33.04% |
| FCF Margin | n/a |
Dividends & Yields
NSE:UNIHEALTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.53% |
| Shareholder Yield | -1.53% |
| Earnings Yield | 2.96% |
| FCF Yield | -2.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |